Author

Remy Thomas

Hamad bin Khalifa University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Adviti NaikiD· 3 shared Julie V. DecockiD· 3 shared Hanan QasemiD· 2 shared Umar Jafar· 2 shared Abdelilah ArredouaniiD· 1 shared Abdi Adam· 1 shared Abdullah AldushainiD· 1 shared Ahmed ZaqoutiD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Adviti NaikORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Longitudinal cellular and humoral immune responses following Covid-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.

Remy Thomas, Ahmed Zaqout, Bakhita Meqbel, Umar Jafar, Nishant N. Vaikath, Abdullah Aldushain, Adviti Naik, Hibah Shaath, Neyla S. Al-Akl, Abdi Adam, Houda Yasmine Ali Moussa, Kyung Chul Shin, Rowaida Ziad Taha, Mohammed Abukhattab, Muna A. Rahman S. AlMaslamani, , Julie V. Decock

This study examines immune responses in craft and manual workers after a BNT162b2 booster, showing enhanced Th1 and cytotoxic T cell responses, and durable humoral immunity, with prior infection boosting B cell counts.

Frontiers in Immunology · Mar 27, 2025Peer-reviewedImmunology

Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer

Adviti Naik, Remy Thomas, Aljazi Al-Khalifa, Hanan Qasem, Julie V. Decock

This study investigates how tumor LDHC expression affects immune responses in breast cancer, finding that LDHC knockdown enhances T cell activation and reduces immunosuppressive factors and checkpoint molecule expression.

Cell Communication and Signaling · Mar 19, 2025Peer-reviewedCancer Biology

Anti-tumor effects of a novel cell penetrating peptide-based therapeutic approach to target Lactate Dehydrogenase C (LDHC) in triple negative breast cancer.

Hanan Qasem, Adviti Naik, Tricia Gomez, Janarthanan Ponraj, Umar Jafar, Martin Sikhondze, Remy Thomas, Khaled A Mahmoud, Julie V. Decock

This paper evaluates four cell-penetrating peptides for delivering LDHC siRNA to TNBC cells, finding that two show effective LDHC knockdown and tumor reduction in zebrafish models.

bioRxiv · Mar 11, 2025 · PreprintCancer Biology